Stocks & Options
Trading Strategies
Institutional Holdings Directory
SEC Filings TLDR
Analysis Reports
AI Tools
EN
Sign in
ARCUTIS BIOTHERAPEUTICS, INC. Reports Q2 2026 Financial Results
2026-08-05
SEC Filing 10-Q
(0001787306-26-000051)
Please check the link below for details.
Ticker mentioned:
ARQT
Source:
Original SEC Document β